What is Rhapsody Orion?
Rhapsody, a health IT interoperability platforms for healthcare organizations for almost 20 years, today announced that it has completed its spin-off from Orion Health in accordance with its acquisition by Hg, a specialist technology investor with deep global healthcare expertise and is now an independent company.
Who owns Rhapsody integration engine?
Two companies with healthcare interoperability engines have agreed to merge. Rhapsody, a Boston-based healthcare interoperability solutions company that was purchased from the Orion Health Group in 2018, is joining forces with Frisco, Texas-based Corepoint Health.
What is Orion in healthcare?
A consumer engagement solution that redefines the healthcare experience. Orion Health’s digital front door is a secure, open, and scalable platform that enables organizations to bring new and existing patient engagement technologies together into a unified, user-friendly hub.
What is communication point in Rhapsody?
A communication point is an interface to an external system. It is the mechanism by which Rhapsody will send and receive information to and from the external systems.
What is Rhapsody health?
The Rhapsody Integration Engine (Rhapsody) is a software suite that provides connectivity and data sharing within and among Hospitals, Information Exchanges and Public Health Organizations. Rhapsody’s integration lays the foundation for the delivery of consistent, efficient and high-quality patient care.
What is corepoint interface engine?
Description: Corepoint Integration Engine is an interface engine that provides message management, routing, mapping, and database access interoperability for hospitals, radiology centers, laboratories, and clinics.
What is an HL7 interface engine?
A HL7 interface engine is an interface or integration engine built specifically for the healthcare industry. It helps connect legacy technology systems by using a standard messaging protocol.
What is Rhapsody healthcare?
Who is CEO of Orion Health?
“Today we made an exciting announcement about investments in Orion Health’s Rhapsody and Population Health businesses from Hg, a specialist technology investor with a deep knowledge of the global healthcare technology sector,” said Ian McCrae (pictured), founder and CEO, Orion Health.
What does an interface engine do?
Interface engines receive incoming messages and route them to the appropriate information systems, and often the engine translates messages into formats that can be understood by the receiving system. Using an interface engine can simplify the integration of various data sources into existing health-it infrastructures.
What is Rhapsody interface?
Rhapsody is a global leading Integration Platform. It supports all healthcare message formats and standards, including HL7 (v2 and v3), HL7® FHIR®, CCDA, NCPDP, X12, IHE, DICOM, XML, binary, delimited and legacy formats.
What is Infor Cloverleaf?
Infor Cloverleaf® Integration Suite software streamlines the exchange of clinical data to help improve healthcare outcomes and business operations.
What happened to Orion Rhapsody?
Orion sells Rhapsody business for £105m. Orion Health has announced plans to sell its core profitable Rhapsody integration engine business to British private investment firm Hg Capital for £105m ($NZ205m), with some of the proceeds to be reinvested in its population health and hospitals divisions.
What does Orion’s acquisition of Hg group mean for Rhapsody?
Orion will continue to 100% own its hospital software division and 75% of its population health business, with Hg to take a 25% shareholding in population health, while Orion will retain a 25% share in Rhapsody.
Who bought out Orion Health Group?
New Zealand-based Orion Health Group announced that it will sell its Rhapsody business unit for $205 million to private equity firm Hg. The U.K.-based firm will also take a quarter stake in Orion’s Population Health unit for $20 million.
What did Orion sell for £105m?
Orion Health has announced plans to sell its core profitable Rhapsody integration engine business to British private investment firm Hg Capital for £105m ($NZ205m), with some of the proceeds to be reinvested in its population health and hospitals divisions.